Literature DB >> 16580728

Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia.

Mark Walterfang1, Stephen J Wood, Dennis Velakoulis, Christos Pantelis.   

Abstract

A wide range of neuropathological abnormalities have been detected in schizophrenia sufferers, and emerging evidence points to neural substrates of connectivity as having a key role in the development of disease. This article reviews the available evidence for white matter pathology in schizophrenia, and examines its possible role as a substrate of impaired connectivity. Neuropathological data is suggestive of abnormalities in glial structure and function, and myelinated structures have also been implicated. A number of studies, particularly using gene array technology, are pointing towards significant disruption in expression of myelination genes. Magnetic resonance imaging has tended to focus on, and detect, more grey than white matter abnormalities, although non-volumetric techniques are suggestive of changes in the microstructure of white matter in schizophrenia. Myelinated structures are an attractive candidate for an anatomical substrate for disconnectivity, and may act synergistically with synaptic changes to result in functional disconnectivity although the relationship between white and grey matter changes in the illness remains unclear.

Entities:  

Mesh:

Year:  2006        PMID: 16580728     DOI: 10.1016/j.neubiorev.2006.02.001

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  42 in total

1.  White matter volume abnormalities and associations with symptomatology in schizophrenia.

Authors:  Nikolaos Makris; Larry J Seidman; Todd Ahern; David N Kennedy; Verne S Caviness; Ming T Tsuang; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

Review 2.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

3.  Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro.

Authors:  Neus Franco-Pons; Jordi Tomàs; Bárbara Roig; Carme Auladell; Lourdes Martorell; Elisabet Vilella
Journal:  J Mol Neurosci       Date:  2008-10-04       Impact factor: 3.444

4.  Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients.

Authors:  Inge Gorynia; Markus Schwaiger; Andreas Heinz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-05-04       Impact factor: 5.270

5.  SOX10 rs139883 polymorphism is associated with the age of onset in schizophrenia.

Authors:  Aihua Yuan; Weidong Li; Tao Yu; Chen Zhang; Dongxiang Wang; Dengtang Liu; Yifeng Xu; Huafang Li; Shunying Yu
Journal:  J Mol Neurosci       Date:  2013-03-02       Impact factor: 3.444

6.  Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.

Authors:  Subroto Ghose; Jeremy M Crook; Cynthia L Bartus; Thomas G Sherman; Mary M Herman; Thomas M Hyde; Joel E Kleinman; Mayada Akil
Journal:  Int J Neurosci       Date:  2008-11       Impact factor: 2.292

7.  Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder.

Authors:  Christa Hercher; Vikramjit Chopra; Clare L Beasley
Journal:  J Psychiatry Neurosci       Date:  2014-11       Impact factor: 6.186

8.  Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls.

Authors:  Fei Wang; Tianzi Jiang; Zhiguo Sun; Siew-Leng Teng; Xingguang Luo; Zhongjun Zhu; Yufeng Zang; Handi Zhang; Weihua Yue; Mei Qu; Tianlan Lu; Nan Hong; Haiyan Huang; Hilary P Blumberg; Dai Zhang
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

9.  Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.

Authors:  Kristine Roy; Joshua C Murtie; Bassem F El-Khodor; Nicole Edgar; S Pablo Sardi; Bryan M Hooks; Marianne Benoit-Marand; Chinfei Chen; Holly Moore; Patricio O'Donnell; Daniela Brunner; Gabriel Corfas
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

10.  White matter microstructure in schizophrenia: effects of disorder, duration and medication.

Authors:  Richard Kanaan; Gareth Barker; Michael Brammer; Vincent Giampietro; Sukhwinder Shergill; James Woolley; Marco Picchioni; Timothea Toulopoulou; Philip McGuire
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.